Article Details

Analyst Research and Ratings: KemPharm, Inc. (KMPH), Nxt-ID, Inc. (NXTD)

Retrieved on: 2019-01-22 04:57:35

Tags for this article:

Click the tags to see associated articles and topics

Analyst Research and Ratings: KemPharm, Inc. (KMPH), Nxt-ID, Inc. (NXTD). View article details on hiswai:

Excerpt

<div><b>Nxt</b>-<b>ID</b>, Inc. (NASDAQ:NXTD) is worth US$32.9 Million and has recently fallen 0% to US$1.3. The latest exchange of 0.29 Million shares is below its ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo